Previously it was reported that transformation of NIH 3T3 fibroblast by the Ha-ras, v-src, v-fms, and A-raf oncogenes decreased the stimulatory effects of phorbol 12-myristate 13-acetate (PMA; 'TPA'), an activator of protein kinase C (PKC), on the phosphorylation of an endogenous 80 kDa substrate and on 86Rb uptake [Wolfman, Wingrove, Blackshear & Macara (1987) J. Biol. Chem. 262, 16546-16552], as well as on sphingomyelin synthesis [Kiss, Rapp & Anderson (1988) FEBS Lett. 240, 221-226]. Here, we investigated how transformation affects the PMA-stimulated hydrolysis of phosphatidylethanolamine (PtdEtn), a recently characterized mechanism which may contribute to the generation of the second messengers phosphatidic acid and 1,2-diacylglycerol. The effects of PMA were compared with those of bryostatin, a non-tumour-promoter activator of PKC. Transformation of NIH 3T3 cells with' Ha-ras, v-raf, or A-raf enhanced the stimulatory effect of PMA on the phospholipase D-mediated hydrolysis of PtdEtn. On the other hand, the effects of bryostatin on PtdEtn hydrolysis were only slightly increased, if at all, in cells transformed with these oncogenes. In crude membrane preparations isolated from these transformed cells, PMA, but not bryostatin, enhanced the combined stimulatory effects of ATP and the GTP analogue guanosine 5'-[y-thio]triphosphate on phospholipase D-mediated PtdEtn hydrolysis. The PKC inhibitor 1-(5-isoquinolinesulphonyl)-2-methylpiperazine inhibited the stimulatory effect of PMA only in intact cells. These results indicate that transformation of cells by certain oncogenes differentially affects phospholipase D-mediated hydrolysis of PtdEtn induced by PMA and bryostatin, suggesting that the action of PMA might involve two different mechanisms.
INTRODUCTION
Protein kinase C (PKC) is a phospholipid-and Ca2l-dependent serine/threonine-specific kinase [1, 2] that is also markedly activated by the potent tumour promoter phorbol 12-myristate 13-acetate (PMA; 'TPA') [3] . This enzyme appears to be of fundamental importance in the regulation of normal cell growth [1] and also may play an important role in oncogene-induced malignant transformation of cells [4-71. This view is supported by a number of observations. For example, the steady-state level of 1,2-diacylglycerol (1,2-DAG), a generally accepted natural activator of PKC [1, 2] , has been found to be elevated in a number of transformed cell populations [6, [8] [9] [10] [11] . Further, transfection of NIH 3T3 fibroblasts with PKC-1 cDNA enhances tumorigenicity of these cells [12, 13] , and cells that overproduce PKC have been shown to be more susceptible to transformation by Ha-ras oncogenes [14] . More recently, on the basis of studies involving the expression of a mutant form of a-PKC in Balb/c 3T3 fibroblasts, Megidish & Mazurek [15] suggested that altered PKC genes themselves may serve as oncogenes.
Interestingly, transformation of NIH 3T3 cells by the Ha-ras, v-fms and v-src oncogenes enhanced the cellular levels of 1,2-DAG and also caused a decrease in the total cellular content of PKC [9, 11] . Perhaps owing to a partial down-regulation of PKC, transformation by these oncogenes caused an attenuation of cellular responsiveness to PMA, including PMA effects on'the phosphorylation of the PKC substrate 80 kDa protein and on 86Rb+ uptake [9, 11] . Recently, Slivka et al. [16] found that in Haras-transformed Madin-Darby canine kidney cells the PMAstimulated release of arachidonic acid and subsequent production ofprostaglandin E2were also decreased. Confirming the emerging general scheme that transformed cells demonstrate an attenuated response to phorbol ester, we previously found that transformation of NIH 3T3 cells by A-rafdiminished the stimulatory effect of PMA on sphingomyelin synthesis [17] .
In the present study we investigated the effect oftransformation of NIH 3T3 cells by Ha-ras and raf on PMA-and bryostatinstimulated hydrolysis of phosphatidylethanolamine (PtdEtn). The ability of PMA to enhance phospholipid hydrolysis is a widespread phenomenon ( [18] and references cited therein) and has been shown to occur in NIH 3T3 cells as well [19, 20] . We found that transformation by Ha-ras, v-raf or A-raf elicited a GTP-dependent stimulatory effect of TPA on PtdEtn hydrolysis. These transformed cells failed to show a similar GTP-dependent enhancement of the stimulatory effect of bryostatin, a nontumour-promoter activator of PKC [21] [22] [23] [24] . [PMA] (nM) Cell culture NIH 3T3 clone 7 fibroblasts were transformed with murine sarcoma virus carrying either the originally identified v-raf(NIH 3T3/F4 (v) raf; [26] ) or human A-raf (NIH 3T3/6A-raf MSV; [27] ). NIH 3T3 cells transfected with Harvey-murine-sarcoma virus [28] were obtained from Dr. Douglas R. Lowy (National Cancer Institute, Bethesda, MD, U.S.A.). Cells were cultured continuously in Dulbecco's modified Eagle's medium (GIBCO) supplemented with 10 % (v/v) fetal-calf serum, penicillin/ streptomycin (50 units/ml and 50 ,ug/ml respectively) and glutamine (2 mM). Cells used in the experiments were seeded [(1-2) x 105/dish] in 100-mm-diameter plastic dishes (Costar), and growing (50-70 % confluent) cell populations were harvested after 2 days in culture.
Measurement of phospholipid hydrolysis in cells prelabelled with '4C-labelled precursors Cells were grown in the presence of [2-'4C]ethanolamine (0.2 ,uCi/ml) for 48 h to about 70-80 % confluency. After this incubation period, cells were washed twice in fresh medium, incubated in serum-containing medium for an additional 2.5 h to diminish the cell concentration of labelled precursors, and then washed again. Cells were harvested by scraping from the dish. The harvested cells, usually pooled from three to five dishes (150 cm2), were again washed with fresh medium. Then, 0.3 ml aliquots [(1.0-1.6) x 106 cells/ml] were incubated (final vol. 0.32 ml) at 37°C in the presence of2 mm unlabelled ethanolamine along with other agents as specified. Incubations were terminated by the addition of 4 ml of chloroform/methanol (1:1, v/v).
Phase separation was initiated by the addition of 3 ml of water. Released radioactivity was determined either before or after fractionation of the water-soluble products of phospholipid hydrolysis. Fractionation of ethanolamine metabolites was performed on columns packed with Dowex-resin-50-WH+ (BioRad Econo-columns; I ml bed volume) as described by Cook & Wakelam [29] for choline derivatives, with minor modifications.
The initial flow-through (5 ml), along with a following 3 ml wash, contained glycerophosphoethanolamine. Ethanolamine phosphate and ethanolamine were eluted with 20 ml of water and 15 ml of 1 M-HCI respectively. For the preparation of appropriate '4C-labelled standards, the prelabelled cells were treated with phospholipase A2 (r unit/ml) + phospholipase B (I unit/ml) and phospholipase C (1 unit/ml) respectively for 60 min, and extracts were prepared as described above. For the determination of the elution profiles of standards (determined in each experiment), 2 ml fractions were collected. The metabolites of [14C]ethanolamine present in the peak fractions were further identified by t.l.c. [19] . In an experiment similar to that described in the legend to Fig. 1 [25] . v/v). Radioactivity was determined either in the water phase, as described above, or in the chloroform phase, as described previously [30, 31] .
RESULTS AND DISCUSSION
The aim of the present study was to determine the effects of PMA and bryostatin, two similarly potent activators of PKC [22, 24] , -on the hydrolysis of PtdEtn in untransformed and transformed NIH 3T3 cells. Previous data indicated that, in NIH 3T3 cells, PMA-stimulated hydrolysis of PtdEtn, similar to that of PtdCho, was mediated by a phospholipase D activity [19] . At lower (2-5 nM) concentrations, PMA had either no effect or a slightly reduced effect on [14C]PtdEtn hydrolysis in the transformed cells (Fig. 1) . In contrast, transformation with these oncogenes potentiated the stimulatory effects of higher concentrations of PMA on PtdEtn hydrolysis (Fig. 1) . In the Haras-and A-raf-transformed cells, the effect of bryostatin was not significantly different from that observed in control cells, and transformation with v-raf caused less potentiation of the bryostatin effect when compared with PMA (Fig. 2) . Thus transformation by Ha-ras, A-raf and v-raf preferentially enhanced the stimulatory effect of PMA on PtdEtn hydrolysis.
We have reported that ATP and GTP synergistically stimulated PtdEtn hydrolysis in crude membranes isolated from NIH 3T3 cells [20] . Thus we decided to investigate the possible interrelationship between the effects of PMA and these nucleotides on PtdEtn hydrolysis in membranes isolated from untransformed and transformed cells prelabelled with [14C]ethanolamine. Special care was taken not to use chelators during membrane isolation, which would likely result in the removal of plasma-membranebound PKC [32] [33] [34] [35] . For the same reason, we avoided extensive washing of membranes. As shown in Table 1 , ATP and GTP [S] had similar synergistic effects on PtdEtn hydrolysis in membranes isolated from either untransformed or Ha-ras-transformed cells. In membranes isolated from the ras-transformed cells, PMA potentiated the combined stimulatory effects of nucleotides on PtdEtn hydrolysis, whereas PMA had no statistically significant effect in membranes from untransformed cells (Table 1) . On the other hand, PMA also potentiated the effects of nucleotides on PtdEtn hydrolysis in membranes isolated from v-raf-or A-raftr&nsformed cells (Table 2 ). In contrast with PMA, bryostatin failed to stimulate PtdEtn hydrolysis in any of these membrane preparations (Tables 1 and 2) . Recently, several laboratories [36] [37] [38] reported that the potent PKC inhibitor 1-(5-isoquinolinesulphonyl)-2-methylpiperazine (H7) [39] (Table 3 ). In the ras-transformed cells, PMA was more potent than bryostatin in stimulating PtdEtn hydrolysis, and the effect ofPMA was also less efficiently inhibited by H7 (Table 3) . Similar to the v-raf-transformed cells, the effect of PMA on PtdEtn hydrolysis was also less effectively inhibited by H7 (results not shown).
In conclusion, these studies suggest that, in transformed NIH 3T3 cells, PMA, but not bryostatin, may regulate PtdEtn hydrolysis through two different mechanisms, one of them being more sensitive to the inhibitory effect of H7 than the other. On the basis of the observed differences between the actions of PMA and bryostatin, tumour-promoting and non-tumour-promoting activators of PKC respectively, we cannot exclude the possibility that the action of PMA on PtdEtn hydrolysis involved, at least in transformed NIH 3T3 cells, both PKC-dependent and -independent mechanisms. This possibility is supported by observations indicating that transformation of NIH 3T3 cells usually leads to attenuated response to PMA [9, 11, 16, 17] . Alternatively, the action of PMA may involve two different isoforms of PKC, one of them acting in a nucleotide-dependent manner and being insensitive to bryostatin and H7. Clearly, bryostatin, which appears to mimic only one action of PMA on PtdEtn hydrolysis, will be a valuable tool in identifying the mechanisms involved in the regulation of phospholipase D activity in transformed cells.
While this manuscript was in preparation, Meulen & Haslam [38] reported that PMA treatment of intact rabbit platelets further enhanced the stimulatory effect of GTP[S] on phospholipase D-mediated hydrolysis of PtdCho in isolated platelet membranes. Furthermore, inhibitors of PKC, including H7 and staurosporine, were relatively ineffective inhibitors of PMA action [38] . These data led Meulen & Haslam [38] 
